GlaxoSmithKline Pharma Limited was incorporated in November 13, 1924. During year 1956, the Company began primary production of vaccines at ... product of UCB Pharma (Belgium) was launched under ...

The role of insects in drug discovery is expanding, with biopharmaceuticals derived from insect cells offering sustainable ...

Recall the Comirnaty® and Spikevax® mRNA-based vaccines each utilize lipid nanoparticles ... the Netherlands, and Belgium from 2022 to 2023. CureVac v. Pfizer+BioNTech In June 2022, longstanding ...

The Leuven, Belgium-based company will apply the new ... Seattle-based Curevo also said Moncef Slaoui, the former GSK vaccine executive and chief scientific advisor to Operation Warp Speed ...

Belgium-based Agomab will use some of the proceeds ... 3 development of its novel group B streptococcus (GBS) preventative vaccine, currently in a pair of phase 2 trials, in pregnant women.

The Leuven, Belgium-based company will apply the new ... Seattle-based Curevo also said Moncef Slaoui, the former GSK vaccine executive and chief scientific advisor to Operation Warp Speed ...

1 Tony Wood, Chief Scientific Officer at GSK, said: "We welcome this positive recommendation that can help strengthen disease prevention efforts in the US. Pentavalent vaccines can reduce the ...

In GSK’s suit against Pfizer, the British pharma was seeking monetary damages or royalties and potentially a permanent injunction on the commercialization of Pfizer’s RSV vaccine in the U.S.

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent ...

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in ...